Latest filingAug 25, 2026Most recent Form 4
APLM
Apollomics Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$825M5 buys
Total selling$00 sells
Net open-market+$825M4 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period7transactions
- P · Open-market buys · dominant5 · 71%
- M · Option exercise2 · 29%
Activity by reported role
A joint filing can contribute to multiple roles7transactions
- Chief executive officer · dominant3 · 43%
- Director2 · 29%
- Chief financial officer1 · 14%
- COO1 · 14%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (4)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeChen Hung-WenCLASS A ORDINARY SHARES · Direct
315,001Aug 14, 2026
Chen Hung-WenCLASS A ORDINARY SHARES · Indirect · Through King Regent Management Limited
1,029,695Aug 14, 2026
Lin Peter Kuan-HowCLASS A ORDINARY SHARES · Direct
48,979Aug 14, 2026
Chen Yi-KueiCLASS A ORDINARY SHARES · Indirect · Through Maxpro Investment Co., Ltd.
121,248Aug 14, 2026
Huang Ya-ChiRestricted Stock Units · Direct
500Aug 17, 2026
Huang Ya-ChiCLASS A ORDINARY SHARES · Direct
1,500Aug 17, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- CH+$7.6M
- LK+$400.0k
- CY+$300.0k
- HY+$0
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
APLM transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| APLM | Huang Ya-Chi | DIR | exercise | 500 | $0 | M | 0.0% | 08/25 | 08/17 | |
| APLM | Huang Ya-Chi | DIR | exercise | 500 | $0 | M | 0.0% | 08/25 | 08/17 | |
| APLM | Chen Yi-Kuei | COO | buy | 20.0k | $30.0M | P | +14.4% | 08/17 | 08/14 | |
| APLM | LIN PETER KUAN-HOW | CFO | buy | 26.6k | $40.0M | P | +14.4% | 08/17 | 08/14 | |
| APLM | Chen Hung-Wen | CEO | buy | 266k | $400M | P | +14.4% | 08/17 | 08/14 | |
| APLM | Chen Hung-Wen | CEO | buy | 103k | $154M | P | +14.4% | 08/17 | 08/14 | |
| APLM | Chen Hung-Wen | CEO | buy | 166k | $200M | P | +14.4% | 08/17 | 08/14 |
Apollomics Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Apollomics Inc.?
Huang Ya-Chi, Chen Yi-Kuei, LIN PETER KUAN-HOW, Chen Hung-Wen.
When was the latest reported open-market purchase?
Chen Yi-Kuei reported a buy on Aug 14, 2026 valued at $30.0M. Read the SEC filing.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
Net open-market buying in the selected period was $8,250,009.00. This describes filed transactions, not a bullish rating.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.